Skip to main content
INCY
NASDAQ Life Sciences

Incyte Raises 2026 Revenue Outlook by $360M After CMS Settlement, Q2 EPS Crushes Estimates

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$119.1
Mkt Cap
$23.748B
52W Low
$69.695
52W High
$120.71
52W Position info
71% above low
Off High info
1.3% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

INCY sits 71% above its 52-week low of $69.695.

Summary

Incyte lifted its 2026 revenue guidance to $5.13B-$5.26B, up from $4.77B-$4.94B, driven by a CMS settlement that adds $300M-$310M to Opzelura net sales. Q2 adjusted EPS of $3.09 demolished the $2.10 consensus, boosted by a $246M non-cash benefit from the settlement. Total Q2 net sales jumped 40% to $1.49B, with Jakafi at $816.7M and Opzelura at $449.7M. The company also discontinued the INCB160058 blood cancer program, a setback that was largely expected. This follows the June 22 settlement announcement and the recent Vega Therapeutics acquisition close. The guidance raise and earnings beat signal strong commercial execution and a favorable regulatory resolution.

At the time of this announcement, INCY was trading at $119.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.7B. The 52-week trading range was $69.70 to $120.71. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

INCY - Latest Insights

INCY
Oct 29, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $116.80
Real-time Price: $120.02 info
Change: +$3.22 (+3%) info
Market Cap: $24.658B info
INCY
Oct 29, 2026, 11:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $115.20
Real-time Price: $120.02 info
Change: +$4.82 (+4%) info
Market Cap: $24.658B info
INCY
Oct 29, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $117.76
Real-time Price: $120.02 info
Change: +$2.26 (+2%) info
Market Cap: $24.658B info
INCY
Aug 31, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $123.22
Real-time Price: $120.02 info
Change: -$3.20 (-3%) info
Market Cap: $24.658B info
INCY
Jul 29, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $119.00
Real-time Price: $120.02 info
Change: +$1.02 (+0.86%) info
Market Cap: $24.658B info